1. 1,3-dimethyl-6-((2-(n-(2-hydroxyethyl)-3-(4-nitrophenyl)propylamino)ethylamino)-2,4(1h),3h)-pyrimidinedione Hydrochloride
2. Ms 551
3. Ms-551
4. Nifekalant
1. 130656-51-8
2. Nifekalant
3. Nifekalant Hcl
4. Ms 551
5. Ms-551
6. 130636-43-0
7. Tpp5r0mdqs
8. Shinbit
9. Dsstox_cid_26495
10. Dsstox_rid_81665
11. Dsstox_gsid_46495
12. 6-[2-[2-hydroxyethyl-[3-(4-nitrophenyl)propyl]amino]ethylamino]-1,3-dimethylpyrimidine-2,4-dione;hydrochloride
13. Nifekalant Hydrochloride (jan)
14. Smr000466369
15. Cas-130636-43-0
16. Unii-tpp5r0mdqs
17. Ncgc00164637-01
18. Shinbit (tn)
19. 1,3-dimethyl-6-((2-(n-(2-hydroxyethyl)-3-(4-nitrophenyl)propylamino)ethylamino)-2,4(1h),3h)-pyrimidinedione Hcl
20. Mls000759497
21. Mls001401449
22. Mls006010783
23. Schembl243693
24. Chembl553090
25. Dtxsid7048374
26. Chebi:31909
27. Hy-b0772a
28. 2,4(1h,3h)-dione Hydrochloride
29. Bcp12511
30. Tox21_112254
31. Nifekalant Hydrochloride [mi]
32. Akos015900502
33. Tox21_112254_1
34. Ac-3499
35. Ccg-100897
36. Nc00147
37. Ncgc00164637-02
38. Nifekalant Hydrochloride [who-dd]
39. 2,4(1h,3h)-pyrimidinedione, 6-((2-((2-hydroxyethyl)(3-(4-nitrophenyl)propyl)amino)ethyl)amino)-1,3-dimethyl-, Monohydrochloride
40. Amino)ethylamino)-1,3-dimethylpyrimidine-
41. Nifekalant Hydrochloride, >=98% (hplc)
42. Db-041979
43. Cs-0014293
44. Ft-0631132
45. D01856
46. 656n518
47. A806121
48. 6-(2-((2-hydroxyethyl)(3-(4-nitrophenyl)propyl)
49. J-005843
50. Q27290131
51. Benzoic Acid,4-(2-aminoethyl)-,1,1-dimethylethyl Ester
52. 6-(2-((2-hydroxyethyl)(3-(4-nitrophenyl)propyl)amino)ethylamino)-1,3-dimethylpyrimidine-2,4(1h,3h)-dione Hydrochloride
53. 6-(2-(2-hydroxyethyl-(3-(4-nitrophenyl)propyl)amino)ethyl Amino)-1,3-dimethylpyrimidine-2,4-dione Hcl
Molecular Weight | 441.9 g/mol |
---|---|
Molecular Formula | C19H28ClN5O5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 10 |
Exact Mass | 441.1778967 g/mol |
Monoisotopic Mass | 441.1778967 g/mol |
Topological Polar Surface Area | 122 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 613 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
LOOKING FOR A SUPPLIER?